On April 1, the U.S. Food and Drug Administration (FDA) approved Foundayo (orforglipron), a new daily pill to treat obesity ...
Stoboclo and Osenvelt were approved as interchangeable biosimilars for bone loss conditions, potentially reducing costs and increasing access. Darzalex Faspro was approved for high-risk smoldering ...
Commercialization of Palforzia, the first FDA-approved peanut allergy oral immunotherapy, will be discontinued at the end of ...
The Food and Drug Administration (FDA) has issued a statement, published electronically in the New England Journal of Medicine (NEJM) on November 12, 2025, proposing a new process for obtaining ...
Gepotidacin, a new oral antibiotic class, was approved for uncomplicated UTIs, showing noninferiority to nitrofurantoin in phase 3 trials. Semaglutide's indications expanded to include cardiovascular ...
The list of products receiving FDA Commissioner priority review vouchers will grow this week to include three psychedelic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results